is semaglutide the same as tirzepatide vs. for weight loss compared Troubling Findings in Study of

This is mainly due to the high prevalence of obesity and related metabolic disorders in the region, driving strong demand for effective treatments

Metformin is now increasingly being used in combination with new incretin-based therapies: glucagon-like peptide 1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors [46], both of which enhance pancreatic beta cell function

The preserved pulsatile GH pattern closely mimics natural physiological secretion, optimizing receptor sensitivity and maximizing anabolic responses in muscle tissue

In the SURMOUNT-5 trial, participants treated with Zepbound achieved an average weight reduction of 20.2% compared to 13.7% with Wegovy at 72 weeks